| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/11/1992 | CA2096944A1 Homo-prostaglandin derivatives as ocular hypotensives |
| 06/11/1992 | CA2096444A1 Novel pilocarpine derivatives and process for their preparation |
| 06/11/1992 | CA2096225A1 Matrix metalloprotease inhibitors |
| 06/11/1992 | CA2057292A1 Labelled, modified oligonucleotides |
| 06/11/1992 | CA2057269A1 Process for the enzymatic preparation of grf(1-44)nh2 |
| 06/11/1992 | CA2056672A1 Halopropargyl mercaptotriazole compounds, compositions, uses and processes of preparation |
| 06/10/1992 | EP0489690A1 Substituted N-Benzoyl-N'-(2-phenylethyl)-piperazines |
| 06/10/1992 | EP0489663A1 Thiazolidine-2,4-dione compound, method for production thereof, and medicine containing the compound for cure diabetic complications |
| 06/10/1992 | EP0489647A2 N,O-sulfated heparosanes; process to produce the same and pharmaceutical compositions containing them |
| 06/10/1992 | EP0489640A1 Use of phenylethanolaminotetralines for preparing antidepressant and anti-stress medicines |
| 06/10/1992 | EP0489616A1 Use in anaesthesia and pharmaceutical compositions of (R)-isoflurane and (R)-desflurane |
| 06/10/1992 | EP0489581A2 Cosmetic composition |
| 06/10/1992 | EP0489579A1 Peptidyl derivatives |
| 06/10/1992 | EP0489577A1 Peptidyl derivatives |
| 06/10/1992 | EP0489548A1 A process for the preparation of 2(R)-methyl-4,4,4-trifluorobutylamine, intermediates, and a process for the preparation of a derivative thereof |
| 06/10/1992 | EP0489547A1 A process for the preparation of a 3-alkylated indole, intermediates, and a process for the preparation of a derivative thereof |
| 06/10/1992 | EP0489458A1 Hydroxyquinolone derivatives |
| 06/10/1992 | EP0489423A1 Bile-acid derivatives, a process for their preparation and their use as medicines |
| 06/10/1992 | EP0489404A2 Method of treating shock using a potassium channel activator |
| 06/10/1992 | EP0489379A1 5-amino-5,6,7,8-tetrahydroquinolines and related compounds, a process for their preparation and their use as medicaments |
| 06/10/1992 | EP0489327A1 Chroman derivatives |
| 06/10/1992 | EP0489308A1 Partricin derivatives |
| 06/10/1992 | EP0489300A2 Tetralones with pharmacological activity |
| 06/10/1992 | EP0489181A1 Solid preparation |
| 06/10/1992 | EP0489153A1 Vaccine compositions containing liposomes |
| 06/10/1992 | EP0489102A1 Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same |
| 06/10/1992 | EP0489045A1 Onset-hastened/enhanced antipyretic response |
| 06/10/1992 | EP0131006B1 Esters of 3-(3-substituted-amino-2-hydroxypropoxy)-4-substituted-1,2,5-thiadiazole derivatives |
| 06/10/1992 | CN1061778A Aminodiol derivatives |
| 06/10/1992 | CN1061775A Hydroxamic acid and n-hydroxyurea derivatives and their use |
| 06/10/1992 | CN1061720A Vitamin-mineral compositions and treatment method |
| 06/10/1992 | CA2098101A1 A vaccine against cholesterol to prevent hypercholesterolemia and atherosclerosis |
| 06/09/1992 | US5120874 Catalytic hydrogenation of benzyl group of corresponding 5-benzyioxy derivative |
| 06/09/1992 | US5120870 Emulsion of lipid containing a prostaglandin analogue |
| 06/09/1992 | US5120855 Formation of hydroxyaromatic ketoacetal from a hydroxyaromatic methylketone and production of 5-(4'-hydroxyphenyl)hydantoin and Dp-hydroxyphenylglycine from 4-hydroxyacetophenone |
| 06/09/1992 | US5120852 Process for preparing (1r,2r)-2-(3-pyridyl)-tetrahydrothiopyran-2-carbothioamide 1-oxides thereby |
| 06/09/1992 | US5120851 Preparation process for making water-soluble lysine salts of (+)2-(4-fluorophenyl)-alpha-methyl-5-benzoxazole acetic acid |
| 06/09/1992 | US5120850 Process for the preparation of morphologically homogeneous forms of thiazole derivatives |
| 06/09/1992 | US5120848 Imidazole derivatives |
| 06/09/1992 | US5120847 Chemical intermediate which can be dehydrohalogenation |
| 06/09/1992 | US5120842 Immunosuppresive activity, antitumor agents, fungicides |
| 06/09/1992 | US5120841 Antibiotics for easy absorption |
| 06/09/1992 | US5120835 Antiinflammatory agents |
| 06/09/1992 | US5120782 Substituted pyrrolo-pyridines pharmaceuticals |
| 06/09/1992 | US5120766 Anticholesterol, antilipemic agent |
| 06/09/1992 | US5120764 Administering penicillamine and allenylamines to inhibit crosslinking of collagen |
| 06/09/1992 | US5120763 Physiologically active and nutritional composition |
| 06/09/1992 | US5120762 Method for production of stabilized sodium ascorbate powder |
| 06/09/1992 | US5120760 Administering gamma-linolenic acid and stearidonic acid |
| 06/09/1992 | US5120759 Tetrahydronaphthalene derivatives for improving short-term memory |
| 06/09/1992 | US5120758 Treating allergic, inflammatory, cardiovascular, pulmonary, arthritic, cutaneous disorders |
| 06/09/1992 | US5120757 Substituted aromatic sulfonamides as antiglaucoma agents |
| 06/09/1992 | US5120753 Chemoprevention of electrophilic damage by mercaptopurine analogs |
| 06/09/1992 | US5120752 Cyclopropyl derivative lipoxygenase inhibitors |
| 06/09/1992 | US5120749 Treatment of anaphylactic shock, respiratory distress syndrome, acute inflammation, delayed cellulosr immunity, parturtition, fetal lung maturation, and cellular differentiation |
| 06/09/1992 | US5120747 Platelet activating factor antagonists |
| 06/09/1992 | US5120744 Substituted (quinolin-2-yl-methoxy)phenylthioureas |
| 06/09/1992 | US5120743 Cyclic anthranilic acid acetic acid derivatives and process for the preparation |
| 06/09/1992 | US5120740 Targeting antitumor drugs to kidneys |
| 06/09/1992 | US5120739 Administering anticonvulsants |
| 06/09/1992 | US5120736 Treatment of functional dysuria associated with hyperactivity of adrenergic smypathetic nervous system |
| 06/09/1992 | US5120735 Synergistic mixture of miconazole, ketoconazole or fluconazole and N-4-tertbutylbenzyl-N-methyl-1-naphthalenemethylamine |
| 06/09/1992 | US5120731 Stabilization of perfluorocarbon emulsions, and perfluorinated heterocyclic compounds usable as emulsion-stabilizing additives |
| 06/09/1992 | US5120729 Beta-lactams as antihypercholesterolemics |
| 06/09/1992 | US5120728 Antibacterial agents |
| 06/09/1992 | US5120727 Rapamycin dimers |
| 06/09/1992 | US5120725 Antibody inhibitors |
| 06/09/1992 | US5120723 Alleviate stress, anxiety, seizures |
| 06/09/1992 | US5120719 Conjugate of prostaglandin and polysaccharide |
| 06/09/1992 | US5120717 Pharmaceutical composition for inhibiting infection with virus causative of acquired human immunodeficiency syndrome |
| 06/09/1992 | US5120713 Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide |
| 06/09/1992 | US5120710 Oral lipid medicinal composition |
| 06/09/1992 | US5120649 Photodynamic inactivation of viruses in blood cell-containing compositions |
| 06/09/1992 | US5120647 Phospholipase a2 inhibitor |
| 06/09/1992 | US5120546 Transdermal system |
| 06/09/1992 | US5120539 Diarrhea therapy for infants |
| 06/09/1992 | US5120538 Turmeric herb extracted oil free of bis-desmethoxycurcumin |
| 06/09/1992 | US5120533 Treatment of ulcers of the gastrointestinal tract using dimethylpolysiloxane |
| 06/09/1992 | US5120530 Fungicides, water-insoluble cationic copolymers; chemical resistance, durability |
| 06/09/1992 | US5120322 Method and apparatus for treatment of fibrotic lesions |
| 06/09/1992 | CA1303294C .alpha.-HYDROXY THIOETHERS |
| 06/09/1992 | CA1303057C P-aminophenols, derivatives thereof and method of use |
| 06/09/1992 | CA1303050C Salt of diclofenac with a cyclic organic base and pharmaceutical compositions which contain it |
| 06/09/1992 | CA1303049C 3-(1h-tetrazol-5-yl)oxanilic acid and salts thereof, method for preparing the same and pharmaceutical compositions containing the compound |
| 06/09/1992 | CA1303048C Diarylakanoids having activity as lipoxygenase inhibitors |
| 06/09/1992 | CA1303045C Selective inhibitors for benzylaminoxidases with respect to other aminoxidases |
| 06/09/1992 | CA1303044C Benzhydryloxyethylpiperidine derivatives process for their preparation and pharmaceutical compositions in which they are present |
| 06/09/1992 | CA1303043C Esters of n-alkyl-nortropines and their quaternary derivatives having anti-bronchospastic activity, process for their preparation and pharmaceutical compositions containing them |
| 06/09/1992 | CA1303042C Piperazinyl-pyridines and piperazinyl-imidazoles and their use as anti-dysrhythmia agents |
| 06/09/1992 | CA1303038C Diselenobis benzoic acid amides of primary heterocyclic amines, process for producing the same and pharmaceutical compounds comprisingthe same |
| 06/09/1992 | CA1303035C Delta _-ll-f28249 compounds |
| 06/09/1992 | CA1303034C Delta _-derivatives of ll-f28249 compounds |
| 06/09/1992 | CA1303032C2 Antiviral nucleosides |
| 06/09/1992 | CA1303031C Pyrimidine derivatives |
| 06/09/1992 | CA1303029C Parasiticides and insecticides |
| 06/09/1992 | CA1303028C Metal complexes of n-methyl-11-aza-10-deoxo-10- dihydroerythromycina or 11-aza-10-deoxo-10- dihydroerythromycin a, method for the manufacture thereof and their use in the manufacture of pharmaceuticals |
| 06/09/1992 | CA1303025C 17-.beta. A-OH 19-NORSTEROIDS SUBSTITUTED IN 17A, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| 06/09/1992 | CA1302927C Efomycin g, its preparation and its use as a yield promoter in animals |
| 06/09/1992 | CA1302892C Peptic ulcer composition containing essential fatty acids |
| 06/09/1992 | CA1302891C Pharmaceutical formulations of acid labile substances for oral use |